Paul J Brett Selected Research

Paul J Brett Research Topics

Disease

30	Melioidosis 02/2024 - 01/2010
9	Infections 01/2024 - 01/2011
7	Glanders 01/2022 - 01/2010
2	Sepsis (Septicemia) 01/2018 - 01/2018
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 08/2014 - 01/2012
1	Bacteremia 05/2017
1	Persistent Infection 05/2015
1	Communicable Diseases (Infectious Diseases) 01/2011

Drug/Important Bio-Agent (IBA)

15	Polysaccharides (Glycans)IBA 02/2024 - 01/2012
14	VaccinesIBA 11/2022 - 04/2011
10	AntigensIBA 02/2024 - 01/2011
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2011
8	AntibodiesIBA 11/2022 - 05/2017
6	Hemolysin Proteins (Hemolysins)IBA 01/2023 - 03/2017
6	Immunoglobulin G (IgG)IBA 11/2022 - 05/2017
5	GlycoconjugatesIBA 01/2024 - 01/2012
5	EnzymesIBA 01/2023 - 01/2018
5	ImmunosorbentsIBA 01/2023 - 01/2018
5	Subunit VaccinesIBA 01/2022 - 02/2011
3	Monoclonal AntibodiesIBA 01/2024 - 03/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 03/2017
2	AerosolsIBA 01/2022 - 01/2019
2	Biological Warfare AgentsIBA 10/2019 - 06/2015
2	Immunoglobulin M (IgM)IBA 09/2019 - 01/2019
2	FlagellinIBA 01/2018 - 05/2017
2	Type VI Secretion SystemsIBA 08/2014 - 01/2010
1	poly(styrene-co-maleic anhydride)IBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Surface Antigens (Surface Antigen)IBA 01/2024
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	cyclopropapyrroloindoleIBA 01/2021
1	LipopolysaccharidesIBA 10/2019
1	EpitopesIBA 10/2019
1	O Antigens (O Antigen)IBA 10/2019
1	Immunoglobulin A (IgA)IBA 09/2019
1	Peptide Elongation Factor Tu (EF-Tu)IBA 01/2019
1	Morphine (MS Contin)FDA LinkGeneric 01/2018
1	CytokinesIBA 01/2018
1	Nonsense Codon (Nonsense Mutation)IBA 05/2017
1	Interleukin-10 (Interleukin 10)IBA 05/2017
1	bis(3',5')-cyclic diguanylic acidIBA 01/2017
1	LatexIBA 09/2015
1	Type III Secretion SystemsIBA 08/2014
1	Type II Secretion SystemsIBA 08/2014
1	Virulence Factors (Pathogenicity Factors)IBA 01/2010

Therapy/Procedure

1	Therapeutics 01/2011